Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
darbepoetin alfa
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Cost-Effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia
Phase:
Phase IV
Type:
Natural history/Epidemiology, Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CR002455
, NCT00264108
2.
R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-Cell Lymphoma
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Active
Age:
66 to 80
Sponsor:
Other
Protocol IDs:
LNH03-6B
, NCT00144755
3.
Phase III Study of Fludarabine and Darbepoetin alfa in Geriatric Patients With Chronic Lymphocytic Leukemia and Comorbidities
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Geriatric
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
GCLLSG-CLL9
, EU-20561, AMGEN-GCLLSG-CLL9, EUDRACT-2005-003014-15, NCT00281892
4.
Anemia Treatment for Advanced NSCLC Patients Receiving Chemotherapy
Phase:
Phase III
Type:
Supportive care
Status:
Approved-not yet active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
20070782
, NCT00858364
5.
Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
GFM-DAR500-2006-01
, NCT00443339
6.
Randomized Study of Adjuvant Chemotherapy With Versus Without Darbepoetin alfa in Women With Stage III Breast Cancer
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
18 to 65
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
WGSG-ARA-PLUS
, AVENTIS-WGSG-ARA-PLUS, SANOFI-WGSF-ARA-PLUS, EU-205108, NCT00309920
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute